US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist
  • 8.260
  • +0.140+1.72%
Trading Apr 30 14:40 ET
1.13BMarket Cap206.50P/E (TTM)

About Aurinia Pharmaceuticals Company

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Company Profile

SymbolAUPH
Company NameAurinia Pharmaceuticals
Listing DateFeb 25, 2000
Founded1993
CEOMr. Peter S. Greenleaf
MarketNASDAQ
Employees130
Fiscal Year Ends12-31
Address14315 – 118 Avenue,Suite 140
CityEdmonton
ProvinceAlberta
CountryCanada
Zip CodeT5L 4S6
Phone1-250-744-2487

Company Executives

  • Name
  • Position
  • Salary
  • Peter S. Greenleaf
  • President, Chief Executive Officer and Director
  • 6.42M
  • Stephen P. Robertson
  • Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer
  • 2.22M
  • Matthew Donley
  • Chief Operating Officer
  • 2.51M
  • Joseph M. Miller
  • Chief Financial Officer and Principal Accounting Officer
  • 2.30M
  • Dr. Greg Keenan, M.D.
  • Chief Medical Officer
  • --
  • Kevin C. Tang
  • Chairman of the Board
  • --
  • Kathy Goetz
  • Independent Director
  • --
  • Jill D. Leversage
  • Independent Director
  • 270.00K
  • Jeffrey Allen Bailey
  • Independent Director
  • 264.49K
  • Craig A. Johnson
  • Independent Director
  • 346.72K
  • Dr. Tina S. Nova, PhD
  • Independent Director
  • --
  • Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
  • Independent Director
  • 256.99K
  • Dr. David R.W. Jayne, F.R.C.P.,M.D.
  • Independent Director
  • 251.33K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More